Cryo-Cell International Inc. (CCEL)

NASDAQ: CCEL · IEX Real-Time Price · USD
6.45
0.00 (0.00%)
May 16, 2022 4:00 PM EDT - Market closed
Market Cap54.57M
Revenue (ttm)29.28M
Net Income (ttm)2.22M
Shares Out8.46M
EPS (ttm)0.27
PE Ratio24.34
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume4,874
Open6.43
Previous Close6.45
Day's Range6.43 - 6.51
52-Week Range6.00 - 14.16
Beta0.47
Analystsn/a
Price Targetn/a
Earnings DateApr 13, 2022

About CCEL

Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technolo...

IndustryHealth Care Providers & Services
IPO DateJan 21, 1997
Employees83
Stock ExchangeNASDAQ
Ticker SymbolCCEL
Full Company Profile

Financial Performance

In 2021, CCEL's revenue was $28.88 million, a decrease of -7.26% compared to the previous year's $31.15 million. Earnings were $2.08 million, a decrease of -42.52%.

Financial Statements

News

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ...

1 month ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store st...

2 months ago - GlobeNewsWire

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store st...

2 months ago - GlobeNewsWire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...

2 months ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...

6 months ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...

7 months ago - GlobeNewsWire

Cryo-Cell International Announces Changes To Its Board of Directors

MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy a...

7 months ago - GlobeNewsWire

Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market

Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company's Common Stock Has Been Approved For Listing On The Nasd...

8 months ago - GlobeNewsWire

Cryo-Cell International Completes Acquisition of Real Estate Property for Its Institute for Cellular Therapies

Cryo-Cell International (symbol: CCEL) Purchases Real Estate Location for its Institute for Cellular Therapies in the Raleigh-Durham area.

8 months ago - GlobeNewsWire

Cryo-Cell International to Present at the Q3 Virtual Investor Summit on August 18, 2021

Oldsmar, Florida--(Newsfile Corp. - August 11, 2021) - Cryo-Cell International (OTC Pink: CCEL) today announced that David Portnoy, Chairman of the board and Co-CEO will be attending the Q3 Virtual Inve...

9 months ago - Newsfile Corp

Cryo-Cell International to Present at the Q3 Virtual Investor Summit

MIAMI, Aug. 11, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International announces that Chairman of the Board and Co-CEO, David Portnoy, will be presenting at the Q3 Virtual Investor Summit on August 18 th , 2021.

9 months ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2021 Financial Results

OLDSMAR, Fla., July 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem c...

10 months ago - GlobeNewsWire

Cryo-Cell International Proudly Announces Two Ongoing COVID-19 Related Trials

MIAMI, May 10, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell's Medical Director, Dr. Joanne Kurtzberg and her research team at The Marcus Center for Cellular Cures (MC3) at Duke University School of Medicine are c...

1 year ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2021 Financial Results

OLDSMAR, Fla., April 14, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ...

1 year ago - GlobeNewsWire